| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.76B | 50.13B | 49.34B | 47.86B | 45.29B | 40.88B |
| Gross Profit | 10.20B | 10.67B | 9.93B | 9.86B | 7.42B | 7.29B |
| EBITDA | 5.94B | 5.63B | 5.80B | 5.87B | 3.67B | 3.87B |
| Net Income | 3.39B | 2.35B | 3.38B | 3.02B | 816.45M | 831.83M |
Balance Sheet | ||||||
| Total Assets | 59.82B | 62.33B | 61.13B | 57.29B | 51.43B | 47.64B |
| Cash, Cash Equivalents and Short-Term Investments | 18.53B | 18.23B | 20.58B | 18.19B | 13.41B | 11.45B |
| Total Debt | 3.08B | 2.00B | 2.80B | 3.00B | 3.20B | 2.90B |
| Total Liabilities | 14.13B | 12.45B | 14.16B | 15.01B | 14.48B | 13.95B |
| Stockholders Equity | 42.96B | 47.00B | 44.18B | 39.93B | 34.90B | 32.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.16B | 3.11B | 5.10B | 1.28B | 351.74M |
| Operating Cash Flow | 0.00 | 2.42B | 5.07B | 7.71B | 3.15B | 2.61B |
| Investing Cash Flow | 0.00 | -122.69M | -3.79B | -3.62B | -2.30B | -2.13B |
| Financing Cash Flow | 0.00 | -2.27B | -1.54B | -913.69M | -168.84M | -718.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥180.84B | 22.82 | ― | 2.84% | 4.10% | 5.25% | |
74 Outperform | ¥543.60B | 15.11 | 6.52% | 1.82% | 4.95% | 52.94% | |
73 Outperform | ¥401.13B | 9.42 | 9.59% | 3.91% | -2.06% | 46.42% | |
70 Outperform | ¥18.95B | 8.26 | ― | 5.21% | 1.61% | -30.23% | |
64 Neutral | ¥437.97B | 4.51 | 8.14% | 2.61% | -0.45% | 50.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥300.16B | -3.18 | 9.34% | 4.27% | -1.18% | -78.57% |